Gut Microbiota and Metabolomics Unveil Sauropi Folium's Laxative Mechanism

In a study published in Fitoterapia, researchers have delved into the mechanisms by which Sauropi Folium aqueous extract (SSAE) might alleviate constipation. Sauropi Folium, derived from the dried leaves of Sauropus spatulifolius Beille, has been traditionally used to treat cough and constipation. However, its chemical makeup and mechanisms of action have remained largely unexplored until now.

Decoding the Chemical Profile

The researchers began by analyzing the chemical profile of SSAE using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). This analysis identified 55 different chemical components within the extract. To predict how these components might exert their effects, the team employed network pharmacology, a method that helps in identifying potential targets and pathways. The analysis suggested that SSAE might influence constipation through several pathways, including those involved in cancer, HIF-1, and PI3K-AKT signaling.

Exploring Effects in a Rat Model

To further investigate, the researchers used a slow transit constipation (STC) rat model induced by loperamide hydrochloride. This model allowed them to assess the physiological effects of SSAE. The study found that SSAE effectively alleviated constipation symptoms in these rats. It also had notable effects on gastrointestinal hormones, neurotransmitters, and improved the colonic pathological morphology.

At the microbiota level, SSAE increased the presence of beneficial bacteria such as the Lachnospiraceae_NK4A136_group while decreasing potential pathogenic bacteria including Allobaculum, Bifidobacterium, Desulfovibrio, and HT002. This shift in microbial composition suggests a potential mechanism by which SSAE might exert its laxative effects.

Metabolomics and Gut Microbiota Interactions

Beyond microbiota changes, the study employed integrated metabolomics to understand the metabolic changes induced by SSAE. The extract was found to upregulate serum glutamine and fecal riboflavin, which are involved in glutamate metabolism, primary bile acid biosynthesis, and purine-polyamine metabolism pathways. These metabolic pathways are crucial for promoting serotonin (5-HT) synthesis, improving intestinal motility, and maintaining mucosal barrier function.

These findings highlight SSAE's potential as a natural remedy for constipation through its multi-level interactions involving chemical constituents, target pathways, gut microbiota, and metabolic networks. However, it is important to note that these results are based on an animal model, which may not fully replicate human physiology.

Limitations and Future Directions

While this study provides valuable insights into the potential mechanisms of SSAE, it is important to recognize its limitations. The research was conducted on a rat model, which, while informative, does not always translate directly to human outcomes. Furthermore, the study's focus on specific pathways and bacteria may overlook other contributing factors. Future research involving human clinical trials would be necessary to confirm these findings and fully understand the implications of SSAE use in humans.

For more on the complexities of gut microbiota, you might find our article on what is the microbiome useful.